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The concerted activities of kinases and phosphatases modulate the phosphorylation levels of
proteins, lipids and carbohydrates in eukaryotic cells. Despite considerable effort, we are still miss-
ing a holistic picture representing, at a proteome level, the functional relationships between
kinases, phosphatases and their substrates. Here we focus on phosphatases and we review and inte-
grate the available information that helps to place the members of the protein phosphatase super-
families into the human protein interaction network. In addition we show how protein interaction
domains and motifs, either covalently linked to the phosphatase domain or in regulatory/adaptor
subunits, play a prominent role in substrate selection.
2012 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Introduction
Phosphorylation is a widespread post-translational modiﬁca-
tion governing signal propagation [1]. Indeed phosphorylation is
an efﬁcient mean to control cell response to internal and external
cues: it is rapid, taking as little as a few seconds, it does not require
new proteins to be synthesized or degraded and can be easily
reverted. Protein phosphorylation plays a key role in controlling
a variety of cellular processes, such as migration, proliferation,
apoptosis, differentiation, metabolism, organelle trafﬁcking,
immunity, learning and memory [2–4]. Thus, it is not surprising
that aberrant phosphorylation proﬁles correlate with disease
conditions such as cancer, diabetes and neurodegenerative or
inﬂammatory disorders [5–7]. Eukaryotic protein phosphorylation
typically occurs on serine, threonine or tyrosine residues. Olsen
et al. have found the distribution of pSer, pThr, pTyr sites in the
human proteome to be around 79.3%, 16.9% and 3.8% respectively
[8]. Furthermore approximately 17000 proteins have at least one
annotated residue in the Phosphosite database [9]. Indeed protein
kinases are one of the largest gene family in eukaryotes, making up
about 2% of the genome [10,11]. The human genome encodes 518al Societies. Published by Elsevier
; LP, lipid phosphatase; PPP,
nt protein phosphatase; HAD,
).protein kinases. 428 are known or predicted to phosphorylate ser-
ine and threonine residues, while the remaining 90 are members of
the tyrosine kinase family [3,12]. By contrast, in the human gen-
ome there are only approximately 200 phosphatases, targeting
phosphorylated proteins or lipids.
Over the past decades, much of the interest of the scientiﬁc com-
munity has focused on protein kinases, protein phosphatases being
considered less interesting house-keeping enzymes playing a non-
speciﬁc role in modulating phosphoprotein homeostasis. Recent
ﬁndings, however, have led to the emerging recognition that pro-
tein phosphatases play key roles in setting the levels of tyrosine,
serine and threonine phosphorylation in cells, thus participating
in the regulation of many physiological processes, including cell
growth, tissue differentiation and inter-cellular communication
[5,13,14].
Many excellent comprehensive reviews have discussed the
different phosphatase superfamilies, their evolution and the mech-
anisms underlying substrate recognition speciﬁcity [13–17,12].
Despite the progress, identiﬁcation of functional in vivo substrates
remains a challenge. As a consequence, we are still missing a
holistic picture representing, at a proteome level, the functional
relationships between phosphatases and substrates. In this short
contribution, we propose a phosphatase classiﬁcation and report
a comprehensive analysis of our current understanding and cover-
age of the phosphatase interactome. Finally, we discuss how this
intricate network of interactions can help to deﬁne the function
of poorly characterized phosphatases and to identify their sub-
strates.B.V. Open access under CC BY-NC-ND license. 
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Fig. 1. Classiﬁcation of protein phosphatase superfamilies. Protein phosphatases were ﬁrst classiﬁed into six different families according to the catalytic domain InterPro
annotation (1). Next each phosphatase family was further subdivided into different classes according to their preferred substrates (2) or literature annotation (3). The number
of phosphatases in each family or class is in parenthesis.
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2.1. A complete compendium of phosphatase domains
A number of reports have discussed in detail the different phos-
phatase superfamilies. Here we aim at a catalogue of all the en-
zymes removing a phosphate group from proteins or lipids,
including their accessory subunits. To obtain such a comprehen-
sive list, we ﬁrst screened the literature and protein databases to
retrieve a list of 250 proteins 194 of which contain a phosphatase
catalytic domain, while the remaining 56 where classiﬁed as regu-
latory subunits (RSs).
Next, to achieve proteome wide coverage of the proteins con-
taining phosphatase domains we used a three step procedure:
(i) we ﬁrst recovered from InterPro [18] the sequences of the cat-
alytic domains and aligned them with the ClustalW2 program
[19]; (ii) clustering analysis allowed the classiﬁcation of the phos-
phatase domains into 13 different subgroups; (iii) each subgroup
alignment was used for a PSI-BLAST search, against the human
proteome [20]. Hits with a p-value <0.001 were either retained
in the group they were already assigned to, or added as new en-
tries to our phosphatase compendium. This strategy resulted in a
collection of 211 Phosphatase catalytic domains distributed in 199
proteins.3. Phosphatase classiﬁcation
The 211 phosphatase domains in the compendium were next
assigned to 6 families deﬁned by catalytic domain sequence simi-
larity, after taking into account InterPro annotations:
- PTP membership is deﬁned by the protein-tyrosine phospha-
tase domain (IPR016130);- PPP by the serine/threonine-speciﬁc protein phosphatase
domain (IPR006186);
- PPM by the Protein phosphatase 2C-like domain (IPR001932);
- HAD by the Haloacid dehalogenase-like hydrolase domain
(IPR005834) or HD domain (IPR023279);
- LP by one of the following three domains: phosphatidic acid
phosphatase (IPR000326), inositol monophosphatase
(IPR000760) and inositol polyphosphate-related phosphatase
(IPR000300);
- NUDT by the NUDIX hydrolase domain (IPR000086).
These six main families were further subdivided into classes,
according to different criteria: sequence homology in the catalytic
domain, substrate speciﬁcity and literature annotation (Fig. 1). The
211 catalytic domains captured by this procedure were aligned
with ClustalW2 and the resulting sequence similarity tree is shown
in Fig. 2. This graphic representation should not be interpreted as
representing an evolutionary relationship between the different
phosphatase superfamilies.4. Catalytic speciﬁcity and substrate selection
Phosphatases have been considered promiscuous enzymes, dis-
playing little intrinsic substrate speciﬁcity when assayed in vitro.
Some published evidence, on the contrary, indicates that they may
showremarkable preference for speciﬁc substrates in vivo. The reac-
tion rate for a speciﬁc substrate is deﬁned by the Michaelis Menten
equation linking the rate of enzymatic reaction to substrate concen-
tration and to the rate constant kcat. Thus, enzymatic speciﬁcitymay
be achieved by increasing the ratio of the catalytic activity of the
enzyme toward physiological substrates over the ‘‘background’’
catalytic activity for similar non-physiological substrates. Such
intrinsic catalytic speciﬁcity can be obtained by shaping the
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Fig. 2. Sequence similarity tree of the phosphatase catalytic domains. The tree illustrates the sequence similarity of domain families that do not have a common ancestor and
should not be interpreted as an evolutionary tree. The phosphatase names are colored according to the classiﬁcation in Fig. 1 and the classiﬁcation of phosphatase catalytic
domain. The tree chart was created by the FigTree software using as input a multiple sequence alignment, generated by ClustalW2 [19] software using a PAM protein weight
matrix, a 25 gap open penalty value and a 0.20 gap extension penalty value.
2734 F. Sacco et al. / FEBS Letters 586 (2012) 2732–2739chemical environment of the substrate binding pocket via side chain
substitutions. Alternatively, protein interactionsmediated either by
adaptor proteins or accessory domains covalently linked to the
phosphatase domain,might favor physiological substrates selection
by increasing their relative local concentration.
The two highly homologous proteins PTPN11/SHP-2 and
PTPN6/SHP-1 offer a clear example of this combined strategy.
PTPN11 uses its amino-terminal SH2 domains to regulate activity
and to increase concentration in speciﬁc cellular compartments.
As a consequence, a catalytically active PTPN11 phosphatase, car-
rying a 65 amino acids deletion in the region encoding for the
SH2 domains, cannot activate MAPK signalling under a variety of
stimulation conditions [21]. However, domain-swapping experi-
ments have provided evidence that the main determinant of sub-
strate speciﬁcity resides in the catalytic domain. For instance,
PTPN11 promotes FGF-2 induced animal cap elongation in Xenopus
oocytes, but a chimeric derivative, where the catalytic domain is
replaced by the PTP domain of PTPN6, fails to do so [22]. On the
same line, only chimeras containing the PTPN6 PTP domain can
dephosphorylate the EGFR [23].
To date, no consensus identifying the preferred phosphopeptide
sequence contexts for Ser/Thr phosphatases could be identiﬁed.We
have carried out an extensive curation of the phosphopeptide sub-
strates reported in the literature without being able to show any
statistically relevant position speciﬁc sequence preference (Libertiet al., submitted). Several reports, on the other hand, have indicated
that the catalytic domains of classical tyrosine phosphatases, when
probed in vitro, display an intrinsic, albeit somewhat weak, prefer-
ence for phosphorylated tyrosine residues embedded in speciﬁc se-
quence contexts [13,24–27].We have recently used a new approach
based on high density phosphopeptide chips to probewith trapping
mutants [28] the substrate preference of the classical PTP against
most of the phosphopeptides in the human proteome (Palma
et al., in preparation). By this approach we have been able to show
that most classical tyrosine phosphatases display an intrinsic sub-
strate preference. From the alignment of the in vitro peptide sub-
strates, it was possible to derive position speciﬁc scoring matrices
that were used to infer putative substrates of the PTPRJ and PTPN1
phosphatases [29,30]. However, not all the peptidesmatching these
weak consensi are targeted by the phosphatases in vivo, supporting
the notion that the enzymatic domains must be guided to their
functional substrates via a network of interactions [13].
5. Adaptors and docking sites
Phosphatases use three main strategies to physically target
their substrates as schematically illustrated in Fig. 3. The three
mechanisms contribute to phosphatase substrate recognition,
although the relative importance of the three in different phospha-
tase families remains to be established.
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F. Sacco et al. / FEBS Letters 586 (2012) 2732–2739 2735One strategy employs targeting domains that are covalently
linked to the catalytic domains (Fig. 3A, strategy I). For instance, as
already mentioned, PTPN11 function depends on the integrity of
the amino terminal SH2 domains [21]. In addition, PTPN11 binds
its substrate GAB1 via SH2-mediated recognition of phosphorylated
tyrosines on the C-terminus of GAB1. Removal of the PTPN11 SH2
binding sites on GAB1 results in hyperphosphorylation of GAB1
[31]. As another example, the FERMdomain of the PTPN21phospha-
tase is necessary to recruit the SRC kinase. After formation of the
FERM-mediated complex SRC is activated via dephosphorylationof its carboxyterminal inhibitory phosphotyrosine. Carlucci et al.
have demonstrated that the expression of PTPN21 lacking either
catalytic activity or the FERM domain cannot promote SRC activa-
tion and cell motility is reduced [32]. As another example, the
TC48 and TC45 isoforms of PTPN2 are characterized by different car-
boxy-termini that are responsible for subcellular localization and, as
a consequence, modulate substrate targeting [33].
Some phosphatases exploit a complementary strategy and use
Small Linear Motifs (SLiM) to dock into a substrate binding pocket
(Strategy II in Fig. 3A). As an example the interaction of the SH3
Table 1
Functional Enrichment of the 24 most represented accessory domains. Domains were
classiﬁed as ‘‘protein interaction domain’’ (according to Jin J. et al. [42]), ‘‘binding’’
(according to InterPro) or ‘‘other’’; p-valuewas calculated by the DAVID web tool [49],
using as input the list of all phosphatases and as background the whole proteome.
Domain type Count p-Value Class Role
Rhodanese-like 14 3,05E-18 PTP Other
NLI interacting factor 7 2,94E-10 HAD Binding
Fibronectin, type III 15 7,47E-04 PTP Protein interaction
domain
RPEL repeat 4 1,12E-04 RS Binding
GRAM 5 1,61E-04 PTP Protein interaction
domain
U2A’/phosphoprotein 4 6,65E-04 RS Other
FERM 5 9,98E-04 PTP Protein interaction
domain
DEK 3 1,32E-03 PTP Protein interaction
domain
MAM 4 2,31E-03 PTP Protein interaction
domain
SH2 7 4,52E-02 PTP,LP Protein interaction
domain
EF-HAND 8 8,74E-02 RS Protein interaction
domain
PH 9 PTP Binding
Ig-like 15 PTP Protein interaction
domain
C2 9 PTP Protein interaction
domain
Arm repeat 8 RS Protein interaction
domain
LR repeat 6 RS Protein interaction
domain
Ank repeat 5 RS Other
Concavalin A-like 4 PTP Protein interaction
domain
WD40 4 RS Protein interaction
domain
FHA 3 PTP,HAD,RS Protein interaction
domain
HEAT 3 RS Protein interaction
domain
Nucleic acid binding 3 PTP,LP Binding
PTB 3 PTP Protein interaction
domain
2736 F. Sacco et al. / FEBS Letters 586 (2012) 2732–2739domain of p130Cas with a proline rich motif in PTPN12 [34] favors
its dephosphorylation by PTPN12 and by this mechanism modu-
lates cell motility [35]. A similar strategy is exploited by a class
of dual speciﬁcity phosphatases (DSPs) that target MAPKs by direct
and speciﬁc interaction of a short segment of the non-catalytic
amino-terminal domain with a receptor surface in the MAPK. For
example, the phosphatase MKP-3/Pyst1 forms a stable complex
only with the ERKs, but not the JNKs or p38 [36]. The speciﬁcity
of this interaction correlates with the selectivity of MKP-3 for
dephosphorylation of the ERKs. The interaction between the two
proteins also stimulates the catalytic activity of the MKP-3 phos-
phatase. One of the sites critical for the interaction of ERKs with
MKP-3 is a 14-residues motif, dubbed KIM, which is also found
in two classical tyrosine phosphatases PTP-SL and STEP, both
regulating the phosphorylation status of ERK1/2 [37]. Also in this
case, selectivity was ascribed to the 14-residues KIM that directly
interacted with ERK proteins. More recently, we have shown that
the trans-membrane receptor protein-tyrosine phosphatase
Density-enhanced phosphatase-1 (DEP-1/PTPRJ) also targets ERKs
via a juxta-membrane KIM motif [29]. Mutations either in the
conserved ERK docking domain or in the PTPRJ KIM motif prevent
ERKs dephosphorylation. The functional relevance of this interac-
tion was conﬁrmed by the observation that PTPRJ KIM-motif point
mutations are frequent in breast cancer metastasis where ERK
kinases are hyper-activated [38].
Finally, some phosphatases bind non-covalently to regulatory
subunits or scaffold proteins that mediate substrate docking
(strategy III in Fig. 3A). For instance, Cong and colleagues have
shown that an adaptor protein PST-PIP1 bridges the PTPN12
phosphatase to its substrate, the ABL kinase, thereby promoting
its dephosphorylation [39]. In another variation of the same
theme, the catalytic subunits of the protein phosphatase 1 (PP1)
contain docking sites that host short linear motifs (SLiM) of reg-
ulatory subunits that in turn direct the phosphatase to speciﬁc
cellular locations and determine substrate speciﬁcity [16]. Also
PPP3CA/Calcineurin requires a regulatory subunit to bind its sub-
strates albeit by a somewhat different mechanism. In stimulatory
conditions, both calcineurin regulatory protein B subunit and
calmodulin bind calcium ions, displacing the auto-inhibitory frag-
ment of the phosphatase domain from the catalytic cleft thereby
activating the enzyme [40]. The PPP3CA substrate speciﬁcity has
been extensively analyzed and two consensus recognition motif
(PxIxIT and LxVP) have been identiﬁed in most of its substrates
[41].6. Association of phosphatase and protein interaction domains
These and other observations emphasize that phosphatases,
similarly to kinases, use protein interaction domains and docking
motifs to modulate the function of their catalytic domains and to
select substrates. To estimate the generality of this strategy we
analyzed the domain architecture of the phosphatase family.
To this purpose, we retrieved the list of InterPro domains asso-
ciated with either phosphatases or regulatory subunits. To simplify
the classiﬁcation, similar InterPro domains sharing a common
‘‘parent’’ term were collapsed into the parent term. Approximately
50% (134 out of 255) of the members of the phosphatase family
display one or more InterPro domains, while 121 have only the cat-
alytic domain. The vast majority of members of this latter group
are members of the PPP, PPM and HAD classes. These differences
in domain association reﬂect different molecular mechanisms of
substrate recognition. For instance, PPPs have evolved an adap-
tor-protein based strategy to target their substrates.
Following this mapping, phosphatases displaying the same do-
main architecture were grouped into classes. This module-basedclassiﬁcation deﬁned 40 groups, 10 ofwhich have only onemember.
In Fig. 3B, we have represented the phosphatase domain relation-
ships as a graph were domain architectures, that are common to
more than one phosphatase, are represented as nodes and nodes
that share at least one domain are linked by an edge. The node size
is proportional to the number of phosphatases that are grouped in
the architectural category, while the node-color describes class
afﬁliation.
In Table 1, we have reported for each domain the total number
of occurrences in the phosphatase family and the p-value of observ-
ing such an occurrence by random sampling. Interestingly, most
phosphatase-associated domains are annotated as linked to pro-
tein interaction by domain experts [42] or to ‘‘binding’’ by InterPro
and their occurrence in the family is often higher than random.
This observation further supports the role of these additional struc-
tures in targeting potential substrates.
The most populated class of domain architectures is repre-
sented by the 14 MAPK phosphatases of the DSP family that are
associated to a Rhodanese-like domain. Although Rhodanese like
motifs are not annotated as ‘‘protein binding’’ modules, it is tempt-
ing to speculate that, in this enzyme family, they have evolved into
MAPK docking modules. Interestingly, despite being one of the
most numerous protein binding domain in the human proteome,
the SH3 domain is not found associated to phosphatases or regula-
tory subunits.
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Fig. 4. The human phosphatase interactome. (A) Graph representation of the human phosphatase interactome. 2496 protein–protein interaction pairs involving one of the
phosphatase proteins were retrieved from the HomoMINT and IntAct databases [43,44]. The network was generated with the Cytoscape graphic software. Squared nodes
represent phosphatases, while rounded grey nodes represent their targets. The phosphatase color code reﬂects class afﬁliation according to the color code convention used
throughout this review. Interactors (circles) of ‘‘cancer PTPs’’ whose biological process is not annotated in UniProtKB with GO terms (B) PTPRG-B, (C) PTPN3, (D) PTPRA and (E)
DUSP1) were extracted from the global phosphatase interactome and marked in different colors, according to their functional association with GO-Biological Process terms.
The phosphatase square nodes are labeled with sectors whose color matches that of the GO-Biological Process term that was signiﬁcantly overrepresented in the phosphatase
interactors and substrates (p-value < 0.002). Edges are colored according to the functional relationships between the nodes they connect: physical associations,
dephosphorylations in red and phosphorylation reactions in green and blue respectively. Continuous and dashed lines represent direct (demonstrated in vitro with puriﬁed
proteins) and indirect dephosphorylation (demonstrated in vivo), respectively.
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Thus, phosphatases and their regulatory subunits are well
equipped with domains specialized in protein/peptide binding that
integrate them in the functional protein interaction network.
Exploration of this intricate web is likely to provide information
about phosphatase function.
To estimate the coverage of the protein interaction network
achieved so far, we undertook a curation effort to capture from
the literature a large fraction of the interactions in which at least
one of the partners is one of the 255 phosphatases or regulatory
subunits in our compendium. This interaction list was merged with
those that could be downloaded from the HomoMINT and Intact
databases [43,44]. The interaction information we collected con-
tributed to assemble an intricate and highly connected network
consisting of 1555 nodes and 2496 edges (Fig. 4A).
While the majority of the phosphatases could be integrated by
this strategy in the human interaction network, for 25 PTPs, 1 PPPand 9 RSs we were not able to retrieve any interaction information.
380 of the 2496 edges in the interactome graph represent ‘‘dephos-
phorylation’’ reactions. Most of these (345) link tyrosine phospha-
tases to their substrates, while we could only recover information
about 35 dephosphorylation reactions mediated by PPPs.
8. Guilt by association
Next we asked whether the phosphatase interaction network
could be used to obtain information about the function of poorly
characterized phosphatases. Recently, Julien et al. reviewed the
functional role of protein tyrosine phosphatases in cancer [45].
For 35 members of this family there is evidence that they affect
transformation and could be classiﬁed as oncogenic or oncosup-
pressor phosphatases, but for 18 of them we hardly have any infor-
mation about the fulﬁlled role or molecular mechanism [45]. To try
to ﬁll this gap, we asked whether the interactors and the substrates
of these phosphatases could provide some hint about the pathways
2738 F. Sacco et al. / FEBS Letters 586 (2012) 2732–2739that are affected by phosphatase activity. The subnetwork of four
of these (PTPRG, PTPN3, PTPRA and DUSP1), once extracted from
the human phosphatase interactome, displayed a sufﬁcient num-
ber of protein partners to encourage a GO term enrichment analy-
sis (Fig. 4). Remarkably, these four phosphatases have been
described as both oncogenes and oncosuppressors, depending on
the cellular context. As illustrated in panel B and C of Fig. 4, PTPRG
and PTPN3 partners are both signiﬁcantly associated to the RTKs
signaling GO-term, suggesting a possible involvement in cancer
onset and progression. Interestingly, we also found that PTPRG
partners, as well as those of PTPRA, are signiﬁcantly associated to
cell migration pathways, which are highly correlated to metastasis
progression [46]. Indeed PTPRA has been previously described as
an oncogene, since it is over-expressed both in colon and head
and neck cancer [45]. The oncogenic properties of PTPRA are med-
iated by its direct dephosphorylation of the SRC kinase on Y527,
which increases FAK activity and consequently cell migration
[47]. It has been shown that PTPRA is signiﬁcantly down-regulated
in breast cancer, where it acts as tumor suppressor, affecting
signaling pathways that are still unknown and attenuating GRB2
mediated signaling [45,48]. Our analysis reveals that PTPRA is also
signiﬁcantly associated to RTK signaling as well as apoptosis, sug-
gesting that these could be the potential mechanisms by which
this tyrosine phosphatase acts as tumor suppressor. Finally, DUSP1
has been correlated with both oncogenic and onco-suppressor
functions depending on the cellular context: in ovarian and liver
cancers it is down-regulated, while in a variety of tumors (Head
and neck, breast, gastric, pancreatic, bladder, ovarian, prostate,
lung and CRC) it is over-expressed [45]. The DUSP1 onco-suppres-
sor property relies on its ability to dephosphorylate the MAPK fam-
ily members ERK and JNK, as conﬁrmed by our analysis. In
addition, as shown in panel E of Fig. 4, DUSP1 partner annotation
is signiﬁcantly enriched in terms pertinent to cell cycle regulation.9. Conclusions
We have reviewed published evidence suggesting that phospha-
tases select their substrates by a combination of enzymatic speciﬁc-
ity (e.g., tyrosine phosphatases) and spatial organization, mediated
by the protein interaction network that modulates subcellular co-
compartmentalization and substrate docking. This emphasizes the
importance of compiling a reliable and complete list of phosphatase
interacting partners in order to correctly place the phosphatase
family in the context of the cell interactome. By combining the data
annotated in protein interaction databases and a new curation cam-
paign, we have been able to recover2500 interactions involving as
many as 185 phosphatases out of the 255 encoded in the human
proteome. These data can now be explored in a publicly available
database (hupho.uniroma2.it). Systematic studies, which are
underway, will soon contribute to extend the coverage of the phos-
phatase interactome. This effort will be instrumental in advancing
our understanding of the rules governing substrate selection by this
enzyme family and provide a unique tool for making sense of phos-
phoprotein homeostasis in the cell. Furthermore, a better under-
standing of the interactions, governed by non enzymatic domains,
may enable the design of selective inhibitors to disrupt the physical
interaction of a phosphatase or a targeting subunit with a speciﬁc
substrate.
We have taken advantage of the current incomplete version of
the phosphatase interactome and combined it with the character-
ization of the peptides substrate preference of PTP, as determined
by a high density peptide chip approach, to develop a strategy to
infer new phosphatase substrates [30]. This is based on the
Bayesian integration of two types of evidence: (i) substrate prefer-
ence obtained by probing with phosphatase domains a largenumber of phosphopeptides arrayed on a glass chip and (ii) WID
(Whole Interactome Distance), a distance matrix detailing the
distance between any pair of proteins in a weighted protein inter-
action graph. The approach was successfully used to infer new sub-
strates of the PTPN1/PTP1B phosphatase. Some of these new
substrates have been validated in vivo [30].
The full characterization of the peptide recognition speciﬁcity of
the different members of the PTP family and the completion of
projects aimed at a higher coverage of the interactions mediated
by phosphatases will allow the application of this strategy to a lar-
ger number of tyrosine phosphatases.
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